| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | G03XC03 |
| UNII: | 337G83N988 |
| InChI Key | GXESHMAMLJKROZ-IAPPQJPRSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C28H31NO2 |
| Molecular Weight | 413.56 |
| AlogP | 5.73 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 32.7 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 31.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| MODULATOR | Estrogen receptor modulator | Other |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 1
|
- | 1-4 | - | - | 26-74 | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 2
|
- | 2-24 | - | - | 26-74 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoporosis | 3 | D010024 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 180916-16-9 |
| ChEBI | 135938 |
| ChEMBL | CHEMBL328190 |
| DrugBank | DB06202 |
| EPA CompTox | DTXSID50171037 |
| FDA SRS | 337G83N988 |
| Guide to Pharmacology | 7542 |
| PDB | C3D |
| PubChem | 216416 |
| SureChEMBL | SCHEMBL26815 |
| ZINC | ZINC000003918428 |